KORU Medical Systems Partners for Innovative Infusion Solutions
KORU Medical Systems Partners for Innovative Infusion Solutions
KORU Medical Systems, Inc. (NASDAQ: KRMD), a prominent medical technology firm, is making strides in the realm of healthcare by announcing a new partnership with a global pharmaceutical company. This agreement aims to develop and receive regulatory approval for a groundbreaking subcutaneous immunoglobulin (SCIg) therapy infusion system tailored for a recently commercialized drug therapy. This collaboration represents a significant move towards enhancing patient-centered healthcare solutions.
A Vision for Enhanced Patient Care
The initiative involves a collaborative effort with SCHOTT Pharma, intending to serve as a cornerstone for future projects. By partnering with SCHOTT Pharma, KORU Medical aspires to create a multifaceted infusion system configurable with both vials and prefilled syringes. Harnessing KORU Medical's advanced infusion technology alongside SCHOTT's pioneering TOPPAC® prefillable polymer syringes (PFS), this project is poised to set new standards in the infusion realm.
Transformative Infusion Technology
Linda Tharby, President and CEO of KORU Medical, highlighted the significance of this collaboration, stating that it represents another milestone in their mission to improve the infusion experience for SCIg patients. She emphasized the necessity for an easy-to-use delivery system that fits seamlessly into patients' lives, fostering better adherence to treatment regimens.
The Freedom System: A Beacon of Innovation
KORU Medical has a solid foundation in providing innovative medical solutions. The company’s flagship product, the FREEDOM Syringe Infusion System, encompasses technologies such as the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers. This system is designed for self-administration at home and is also suitable for use in ambulatory infusion centers, showcasing its versatility in diverse healthcare settings.
Empowering Patients with Advanced Solutions
With FDA clearance received in 1994, the Freedom System has evolved significantly, consistently improving the quality of life for patients worldwide. Its design emphasizes user-friendliness, making it an ideal choice for individuals requiring home therapy. The system also encompasses customization capabilities, allowing KORU Medical to tailor solutions for biopharmaceutical companies involved in clinical trials.
Looking Forward: A Commitment to Patient-Centric Innovation
As KORU Medical embarks on this new project, their commitment to patient-centered principles remains at the forefront. The company aims not just to improve healthcare delivery but also to foster a sense of empowerment among patients who rely on their innovations for daily treatment. By integrating new formats such as prefilled syringes, KORU Medical strives to enhance the convenience and efficacy of therapies.
Collaborative Endeavors for Future Projects
The partnership with SCHOTT Pharma marks the beginning of a promising journey filled with potential. KORU Medical envisions this as the first of many initiatives that will combine insights from both organizations to enhance infusion technologies further. Ultimately, this collaboration intends to refine the patient experience and bring innovative solutions to a larger audience.
Frequently Asked Questions
What is the primary goal of KORU Medical's new agreement?
The primary goal is to develop a next-generation subcutaneous immunoglobulin infusion system for commercialized drug therapy.
How will SCHOTT Pharma be involved in this project?
SCHOTT Pharma will collaborate closely with KORU Medical to create an infusion system that can work with both vials and prefilled syringes.
What products does KORU Medical currently offer?
KORU Medical offers the FREEDOM Syringe Infusion System, which includes FREEDOM60® and FreedomEdge® Syringe Infusion Drivers.
When did KORU Medical receive FDA clearance for their Freedom System?
KORU Medical received FDA clearance for the Freedom System in 1994.
What does the company emphasize in its mission?
KORU Medical emphasizes providing innovative, patient-centric solutions that improve quality of life for individuals managing their health.
About The Author
Contact Addison Perry privately here. Or send an email with ATTN: Addison Perry as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
